A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population

2006 ◽  
Vol 16 (2) ◽  
pp. 179-189 ◽  
Author(s):  
Lis Ribu ◽  
Berit Rokne Hanestad ◽  
Torbjorn Moum ◽  
Kåre Birkeland ◽  
Tone Rustoen
Keyword(s):  
Quality Of Life ◽  
General Population ◽  
Diabetic Foot ◽  
Foot Ulcers ◽  
Diabetic Foot Ulcers ◽  
Health Related Quality ◽  
Diabetes Group ◽  
Related Quality ◽  
Health Related

Advancements in improving health-related quality of life in patients living with diabetic foot ulcers

2018 ◽  
Vol 13 (6) ◽  
pp. 307-316 ◽  
Author(s):  
Evangelia Tzeravini ◽  
Anastasios Tentolouris ◽  
Nikolaos Tentolouris ◽  
Edward B. Jude
Keyword(s):  
Quality Of Life ◽  
Diabetic Foot ◽  
Foot Ulcers ◽  
Diabetic Foot Ulcers ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Health-Related Quality of Life in Adrenocortical Carcinoma

Cancers ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 1500 ◽  
Author(s):  
Rebecca V. Steenaard ◽  
Laura A. Michon ◽  
Harm R. Haak
Keyword(s):  
Quality Of Life ◽  
General Population ◽  
Adrenocortical Carcinoma ◽  
Treatment Options ◽  
Clinical Aspects ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
The Impact

Insight into the health-related quality of life (HRQoL) impact of adrenocortical carcinoma (ACC) is important. The disease and its treatment options potentially have an impact on HRQoL. For patients with limited survival, HRQoL research is of utmost importance. We will therefore provide an overview of HRQoL studies in patients with ACC. We found six studies that measured HRQoL in 323 patients with ACC (3 cross-sectional, 1 cohort, 2 trials), all indicating a reduced HRQoL compared to the general population. The FIRMACT trial found that HRQoL of patients with ACC was reduced compared to the general population, and that chemotherapy-mitotane further reduced HRQoL even though survival improved. Clinical aspects of the disease, including cortisol and aldosterone production and adrenal insufficiency have shown great impact on HRQoL in benign disease, even after the recovery of hormonal status. However, the impact of malignant adrenal disease and treatment options on HRQoL including adrenalectomy, radiotherapy, mitotane therapy, and chemotherapy have not been sufficiently studied in patients with ACC. Although the number of HRQoL studies in patients with ACC is limited, the existing literature does indicate that ACC has a large impact on patients’ HRQoL, with disease specific aspects. Further HRQoL research in patients with ACC is essential to improve patient-centered care, preferably by using an ACC-specific HRQoL questionnaire.

scholarly journals Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life

PeerJ ◽  
2013 ◽  
Vol 1 ◽  
pp. e98 ◽  
Author(s):  
Robert Johansson ◽  
Per Carlbring ◽  
Åsa Heedman ◽  
Björn Paxling ◽  
Gerhard Andersson
Keyword(s):  
Quality Of Life ◽  
General Population ◽  
Point Prevalence ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related
Sign in / Sign up

Export Citation Format

Share Document